Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a rando... This is the first randomised controlled trial of CAR T-cell therapy in solid tumours globally. Satri-cel treatment resulted in a significant improvement in progression-free survival, with a manageable...

manuscript: www.thelancet.com/journals/lan...

#Oncology #CAR_T #GastricCancer #ESMO #Immunotherapy #CLDN18 #Satricel #PrecisionMedicine